Follow-up of operable breast cancer

Follow-up of operable breast cancer

Follow-up after initial therapy routinely includes clinical exam ination every 3 months for 2 years, followed by every 6 months for the next 3 years. Thereafter the follow-up is scheduled yearly . A mammogram is also scheduled yearly . Patients with an implant and those with BRCA or other genetic mutations need contrast breast MRI annually . Development of any new symptom or sign during follow-up merits detailed clinical evaluation and relevant investigation. Patients presenting with metastatic disease and those with a local/systemic recurrence are seen more frequently depending on the clinical condition.